These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15188710)

  • 1. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities.
    Hellard ME; Hocking JS; Crofts N
    Epidemiol Infect; 2004 Jun; 132(3):409-15. PubMed ID: 15188710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tattooing in prisons--not such a pretty picture.
    Hellard ME; Aitken CK; Hocking JS
    Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system.
    Poulin C; Courtemanche Y; Serhir B; Alary M
    Ann Epidemiol; 2018 Apr; 28(4):231-235. PubMed ID: 29576049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
    Butler T; Boonwaat L; Hailstone S; Falconer T; Lems P; Ginley T; Read V; Smith N; Levy M; Dore G; Kaldor J
    Aust N Z J Public Health; 2007 Feb; 31(1):44-50. PubMed ID: 17333608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
    Miller ER; Bi P; Ryan P
    Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway.
    Holsen DS; Harthug S; Myrmel H
    Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):673-6. PubMed ID: 7694850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B and hepatitis C and risk factors in prisoners in Lebanon.
    Mahfoud Z; Kassak K; Kreidieh K; Shamra S; Ramia S
    J Infect Dev Ctries; 2010 Mar; 4(3):144-9. PubMed ID: 20351454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Violence and hepatitis C transmission in prison-A modified social ecological model.
    Sazzad HMS; McCredie L; Treloar C; Lloyd AR; Lafferty L
    PLoS One; 2020; 15(12):e0243106. PubMed ID: 33259565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous drugs abuse as the main risk factor of increasing hepatitis C infection prevalence in prisoners in Zenica, Bosnia and Herzegovina.
    Hodžić H; Bajramović A; Obradović Z; Mahmić-Kaknjo M
    Med Glas (Zenica); 2017 Feb; 14(1):73-78. PubMed ID: 28165441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
    Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L
    Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis C virus infection and risk factors of drug using prisoners in Guilan province.
    Mohtasham Amiri Z; Rezvani M; Jafari Shakib R; Jafari Shakib A
    East Mediterr Health J; 2007; 13(2):250-6. PubMed ID: 17684845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017.
    Crowley D; Lambert JS; Betts-Symonds G; Cullen W; Keevans M; Kelly E; Laird E; McHugh T; McKiernan S; Miggin SJ; Murphy C; Murtagh R; O'Reilly D; Tobin C; Van Hout MC
    Euro Surveill; 2019 Apr; 24(14):. PubMed ID: 30968825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting.
    Lafferty L; Rance J; Treloar C
    Drug Alcohol Depend; 2018 Feb; 183():96-101. PubMed ID: 29245104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low incidence of hepatitis C virus among prisoners in Scotland.
    Taylor A; Munro A; Allen E; Dunleavy K; Cameron S; Miller L; Hickman M
    Addiction; 2013 Jul; 108(7):1296-304. PubMed ID: 23297816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs.
    Snow KJ; Young JT; Preen DB; Lennox NG; Kinner SA
    BMC Public Health; 2014 Aug; 14():830. PubMed ID: 25113132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk drug-use practices among a large sample of Australian prisoners.
    Kinner SA; Jenkinson R; Gouillou M; Milloy MJ
    Drug Alcohol Depend; 2012 Nov; 126(1-2):156-60. PubMed ID: 22658284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquiring hepatitis C in prison: the social organisation of injecting risk.
    Treloar C; McCredie L; Lloyd AR;
    Harm Reduct J; 2015 Apr; 12():10. PubMed ID: 25903401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
    Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
    PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie.
    Bird AG; Gore SM; Cameron S; Ross AJ; Goldberg DJ
    AIDS; 1995 Jul; 9(7):801-8. PubMed ID: 7546427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prisoners are at risk for hepatitis C transmission.
    Butler T; Kariminia A; Levy M; Kaldor J
    Eur J Epidemiol; 2004; 19(12):1119-22. PubMed ID: 15678792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.